Dai Ichi Life Insurance Company, LTD Regeneron Pharmaceuticals, Inc. Transaction History
Dai Ichi Life Insurance Company, LTD
- $3.9 Billion
- Q3 2024
A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 12,392 shares of REGN stock, worth $8.85 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
12,392
Previous 14,775
16.13%
Holding current value
$8.85 Million
Previous $15.5 Million
16.11%
% of portfolio
0.33%
Previous 0.38%
Shares
23 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.66 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.03 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.35 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.5 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.07 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.6B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...